Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer

Author： Akay Catherine L.   Ueno Naoto T.   Chisholm Gary B.   Hortobagyi Gabriel N.   Woodward Wendy A.   Alvarez Ricardo H.   Bedrosian Isabelle   Kuerer Henry M.   Hunt Kelly K.   Huo Lei   Babiera Gildy V.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|9|1319-1328

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.9, 2014-05, pp. : 1319-1328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Regular coffee consumption may improve survival in patients with colon cancer

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4102-4103

Blackwell Publishing

Access to resources Recommend Favorite

First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer

By Gill S.  

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 27-44

Adis International

Access to resources Recommend Favorite

Cost-Utility Analysis of Survival with Epoetin-Alfa versus Placebo in Stage IV Breast Cancer

By Martin S.C.  

PharmacoEconomics, Vol. 21, Iss. 16, 2003-01 ,pp. : 1153-1169

Adis International

Access to resources Recommend Favorite

Sorafenib may improve response rate and progression-free survival (PFS) duration in patients with iodine refractory thyroid cancer

By  

Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

APC 8015 may improve survival duration in prostate cancer

By  

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite